PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1176

  1. 154 Posts.
    lightbulb Created with Sketch. 85
    Thanks. I wasn't interested from an investor perspective, more so as competitive nature to PAR, both targeting OA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.